Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
234.19
+0.26 (0.11%)
Apr 24, 2024, 4:00 PM EDT - Market closed

Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.
Inspire Medical Systems logo
Country United States
Founded 2007
IPO Date May 3, 2018
Industry Medical Devices
Sector Healthcare
Employees 1,011
CEO Timothy P. Herbert

Contact Details

Address:
5500 Wayzata Blvd, Suite 1600
Golden Valley, Minnesota 55416
United States
Phone 763-957-5037
Website inspiresleep.com

Stock Details

Ticker Symbol INSP
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001609550
CUSIP Number 457730109
ISIN Number US4577301090
Employer ID 26-1377674
SIC Code 3841

Key Executives

Name Position
Timothy P. Herbert Chief Executive Officer, President and Director
Richard J. Buchholz Chief Financial Officer
Philip J. Ebeling Chief Operating Officer
Randall A. Ban Chief Commercial Officer
Dr. Charisse Y. Sparks FAAOS, M.D. Chief Medical Officer
Carlton W. Weatherby Chief Strategy Officer
John C. Rondoni Chief Technology Officer
Ezgi Yagci Vice President of Investor Relations
Bryan K. Phillips Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Steven L. Jandrich Vice President of Human Resources

Latest SEC Filings

Date Type Title
Apr 17, 2024 144 Filing
Apr 1, 2024 144 Filing
Apr 1, 2024 144 Filing
Apr 1, 2024 144 Filing
Mar 25, 2024 144 Filing
Mar 22, 2024 144 Filing
Mar 19, 2024 ARS Filing
Mar 19, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 19, 2024 DEF 14A Other definitive proxy statements
Mar 18, 2024 144 Filing